Atlas Trials

Suzhou Immunofoco Biotechnology Co., Ltd

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Suzhou Immunofoco Biotechnology Co., Ltd

RecordFirmDate
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma (NCT07493135)Suzhou Immunofoco Biotechnology Co., Ltd2026-03-31
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors. (NCT07644403)Suzhou Immunofoco Biotechnology Co., Ltd2026-03-05
A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NCT07376642)Suzhou Immunofoco Biotechnology Co., Ltd2025-12-29
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients (NCT07103668)Suzhou Immunofoco Biotechnology Co., Ltd2025-08-06
A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors (NCT05946226)Suzhou Immunofoco Biotechnology Co., Ltd2023-09-07
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression (NCT05472857)Suzhou Immunofoco Biotechnology Co., Ltd2022-08-08

Track Suzhou Immunofoco Biotechnology Co., Ltd automatically

Every clearance here is in the API, with alerts when new ones post.